Inhibikase Therapeutics (IKT)
NASDAQ:IKT
Advertisement

Inhibikase Therapeutics (IKT) Market Cap & Net Worth

Compare
167 Followers

Inhibikase Therapeutics Market Cap

Inhibikase Therapeutics has a market cap or net worth of $118.48M as of Nov 16, 2025. Its market cap has increase by 550.67% in one year.
Market Cap
$118.48M
Enterprise Value
$87.89M
1-Year Change
550.67%
Category
Micro (Under 300M)
Stock Price
$1.53

Market Cap Chart

Market Cap History
Date
Market Cap
% Change
Nov 14, 2025
114.01M-4.37%
Nov 13, 2025
119.23M-1.23%
Nov 12, 2025
120.72M-1.22%
Nov 11, 2025
122.21M+3.14%
Nov 10, 2025
118.48M+6.00%
Nov 07, 2025
111.77M+0.67%
Nov 06, 2025
111.03M-12.35%
Nov 05, 2025
126.68M+6.92%
Nov 04, 2025
118.48M-0.62%
Nov 03, 2025
119.23M+8.84%
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis